{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:33:19Z","timestamp":1783783999902,"version":"3.55.0"},"reference-count":35,"publisher":"e-Century Publishing Corporation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/qkpv5157","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T04:18:36Z","timestamp":1732853916000},"page":"6668-6678","source":"Crossref","is-referenced-by-count":4,"title":["Safety and effectiveness of dual trigger (GnRH agonist + HCG) versus HCG alone in patients with high ovarian response"],"prefix":"10.62347","volume":"16","author":[{"given":"Xiaoli","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1056\/NEJMc2211539","article-title":"Unexplained female infertility associated with genetic disease variants","volume":"388","author":"Dougherty","year":"2023","unstructured":"Dougherty MP, Poch AM, Chorich LP, Hawkins ZA, Xu H, Roman RA, Liu H, Brakta S, Taylor HS, Knight J, Kim HG, Diamond MP and Layman LC. Unexplained female infertility associated with genetic disease variants. N Engl J Med 2023; 388: 1055-1056.","journal-title":"N Engl J Med"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1177\/1098612X221118752","article-title":"Infertility in Queens: clinical approach, experiences and challenges","volume":"24","author":"Fontbonne","year":"2022","unstructured":"Fontbonne A. Infertility in Queens: clinical approach, experiences and challenges. J Feline Med Surg 2022; 24: 825-836.","journal-title":"J Feline Med Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/1471-0528.14966","article-title":"Epidemiology of infertility in China: a population-based study","volume":"125","author":"Zhou","year":"2018","unstructured":"Zhou Z, Zheng D, Wu H, Li R, Xu S, Kang Y, Cao Y, Chen X, Zhu Y, Xu S, Chen ZJ, Mol BW and Qiao J. Epidemiology of infertility in China: a population-based study. BJOG 2018; 125: 432-441.","journal-title":"BJOG"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Koatz JG and Souza MDCB. Obese women and in vitro fertilization: results. JBRA Assist Reprod 2022; 17: 353-356.","DOI":"10.5935\/1518-0557.20130080"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/humrep\/deaa107","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study","volume":"35","author":"Haas","year":"2020","unstructured":"Haas J, Bassil R, Samara N, Zilberberg E, Mehta C, Orvieto R and Casper RF. GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: a double-blinded, randomized controlled study. Hum Reprod 2020; 35: 1648-1654.","journal-title":"Hum Reprod"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"830567","DOI":"10.3389\/fendo.2022.830567","article-title":"Low endogenous LH on the COS initiation day of a GnRH-agonist regimen increases the risk of early pregnancy loss and adverse ART outcomes","volume":"13","author":"Luo","year":"2022","unstructured":"Luo X, Li L, Lin N, Ma R, Li Y and Wu Z. Low endogenous LH on the COS initiation day of a GnRH-agonist regimen increases the risk of early pregnancy loss and adverse ART outcomes. Front Endocrinol (Lausanne) 2022; 13: 830567.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1472-6483(10)60633-5","article-title":"Optimum number of oocytes for a successful first IVF treatment cycle","volume":"13","author":"van der Gaast","year":"2006","unstructured":"van der Gaast MH, Eijkemans MJ, van der Net JB, de Boer EJ, Burger CW, van Leeuwen FE, Fauser BC and Macklon NS. Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 2006; 13: 476-480.","journal-title":"Reprod Biomed Online"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","unstructured":"Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J and Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod 2011; 26: 1768-1774.","journal-title":"Hum Reprod"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"101643","DOI":"10.1016\/j.jogoh.2019.101643","article-title":"A prospective randomized controlled pilot study","volume":"49","author":"Tshzmachyan","year":"2020","unstructured":"Tshzmachyan R and Hambartsoumian E. The role of Letrozole (LE) in controlled ovarian stimulation (COS) in patients at high risk to develop ovarian hyper stimulation syndrome (OHSS). A prospective randomized controlled pilot study. J Gynecol Obstet Hum Reprod 2020; 49: 101643.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1080\/01443615.2019.1674262","article-title":"GnRH agonist versus HCG triggering in different IVF\/ICSI cycles of same patients: a retrospective study","volume":"40","author":"Y&#x131","year":"2020","unstructured":"Yılmaz N, Ceran MU, Ugurlu EN, Gülerman HC and Engin Ustun Y. GnRH agonist versus HCG triggering in different IVF\/ICSI cycles of same patients: a retrospective study. J Obstet Gynaecol 2020; 40: 837-842.","journal-title":"J Obstet Gynaecol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/s41598-022-08400-z","article-title":"Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis","volume":"12","author":"Kadoura","year":"2022","unstructured":"Kadoura S, Alhalabi M and Nattouf AH. Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis. Sci Rep 2022; 12: 4456.","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"20420188231173325","DOI":"10.1177\/20420188231173325","article-title":"Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review","volume":"14","author":"KKW","year":"2023","unstructured":"Kuan KKW, Omoseni S and Tello JA. Comparing ART outcomes in women with endometriosis after GnRH agonist versus GnRH antagonist ovarian stimulation: a systematic review. Ther Adv Endocrinol Metab 2023; 14: 20420188231173325.","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1080\/03009734.2020.1737599","article-title":"Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention","volume":"125","author":"JC","year":"2020","unstructured":"Castillo JC, Haahr T, Martínez-Moya M and Humaidan P. Gonadotropin-releasing hormone agonist ovulation trigger-beyond OHSS prevention. Ups J Med Sci 2020; 125: 138-143.","journal-title":"Ups J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Ryniec J and Esfandiari N. Early serum hCG in IVF: are we trending in the right direction? Reprod Sci 2021; 28: 1827-1838.","DOI":"10.1007\/s43032-020-00347-8"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/humrep\/deac114","article-title":"Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles","volume":"37","author":"Zhou","year":"2022","unstructured":"Zhou C, Yang X, Wang Y, Xi J, Pan H, Wang M, Zhou Y and Xiao Y. Ovulation triggering with hCG alone, GnRH agonist alone or in combination? A randomized controlled trial in advanced-age women undergoing IVF\/ICSI cycles. Hum Reprod 2022; 37: 1795-1805.","journal-title":"Hum Reprod"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10815-023-02888-8","article-title":"Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials","volume":"40","author":"Hsia","year":"2023","unstructured":"Hsia LH, Lee TH, Lin YH, Huang YY, Chang HJ and Liu YL. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials. J Assist Reprod Genet 2023; 40: 2063-2077.","journal-title":"J Assist Reprod Genet"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Ovarian Stimulation TEGGO, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G, Le Clef N, Massin N, Mastenbroek S, Polyzos N, Sunkara SK, Timeva T, Töyli M, Urbancsek J, Vermeulen N and Broekmans F. ESHRE guideline: ovarian stimulation for IVF\/ICSI(†). Hum Reprod Open 2020; 2020: hoaa009.","DOI":"10.1093\/hropen\/hoaa009"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Zheng D, Zeng L, Yang R, Lian Y, Zhu YM, Liang X, Tang L, Wang H, Cao Y, Hao G, Liu J, Zhao J, Wang R, Mol BW, Li R, Huang HF and Qiao J. Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial. BMJ Open 2019; 9: e030366.","DOI":"10.1136\/bmjopen-2019-030366"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/03009734.2019.1684405","article-title":"Use of in vitro fertilization-ethical issues","volume":"125","author":"Asplund","year":"2020","unstructured":"Asplund K. Use of in vitro fertilization-ethical issues. Ups J Med Sci 2020; 125: 192-199.","journal-title":"Ups J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jen.2022.09.006","article-title":"Ovarian hyperstimulation syndrome: a case report","volume":"49","author":"Adams","year":"2023","unstructured":"Adams A and Adams C. Ovarian hyperstimulation syndrome: a case report. J Emerg Nurs 2023; 49: 8-11.","journal-title":"J Emerg Nurs"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.ajem.2019.05.018","article-title":"Ovarian hyperstimulation syndrome: a review for emergency clinicians","volume":"37","author":"Timmons","year":"2019","unstructured":"Timmons D, Montrief T, Koyfman A and Long B. Ovarian hyperstimulation syndrome: a review for emergency clinicians. Am J Emerg Med 2019; 37: 1577-1584.","journal-title":"Am J Emerg Med"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"178","DOI":"10.23736\/S2724-606X.21.04806-5","article-title":"Ovarian hyperstimulation syndrome and adverse pregnancy outcome","volume":"74","author":"Buca","year":"2022","unstructured":"Buca D, D’Antonio F, Liberati M, Tinari S, Pagani G, Greco P and Nappi L. Ovarian hyperstimulation syndrome and adverse pregnancy outcome. Minerva Obstet Gynecol 2022; 74: 178-185.","journal-title":"Minerva Obstet Gynecol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"615957","DOI":"10.3389\/fendo.2020.615957","article-title":"Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI","volume":"11","author":"Sun","year":"2021","unstructured":"Sun B, Ma Y, Li L, Hu L, Wang F, Zhang Y, Dai S and Sun Y. Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI. Front Endocrinol (Lausanne) 2021; 11: 615957.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"688264","DOI":"10.3389\/fpubh.2021.688264","article-title":"Efficacy of high-intensity focused ultrasound combined with GnRH-a for adenomyosis: a systematic review and meta-analysis","volume":"9","author":"Pang","year":"2021","unstructured":"Pang LL, Mei J, Fan LX, Zhao TT, Li RN and Wen Y. Efficacy of high-intensity focused ultrasound combined with GnRH-a for adenomyosis: a systematic review and meta-analysis. Front Public Health 2021; 9: 688264.","journal-title":"Front Public Health"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13048-022-01044-7","article-title":"Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China","volume":"15","author":"Tian","year":"2022","unstructured":"Tian L, Xia L and Wu Q. Retrospective analysis of GnRH-a prolonged protocol for in vitro fertilization in 18,272 cycles in China. J Ovarian Res 2022; 15: 110.","journal-title":"J Ovarian Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1080\/01443615.2022.2081490","article-title":"Factors affecting clinical pregnancy in controlled ovarian hyperstimulation with GnRH-a long protocol: a retrospective cross-sectional study","volume":"42","author":"Fan","year":"2022","unstructured":"Fan Y, Sun YF, Xu YM, Cao ZY, Luo ZY, Sun Y, Zhao ZM, Hao GM and Gao BL. Factors affecting clinical pregnancy in controlled ovarian hyperstimulation with GnRH-a long protocol: a retrospective cross-sectional study. J Obstet Gynaecol 2022; 42: 2486-2491.","journal-title":"J Obstet Gynaecol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000524904","article-title":"Ovarian hyperstimulation syndrome after GnRH agonist triggering and Freeze-all protocol? Never not, hardly ever: a systematic review of case reports","volume":"87","author":"Iorio","year":"2022","unstructured":"Iorio GG, Carbone L, Conforti A, Rovetto MY, Picarelli S, Cariati F, Strina I, Papanikolaou E and Alviggi C. Ovarian hyperstimulation syndrome after GnRH agonist triggering and Freeze-all protocol? Never not, hardly ever: a systematic review of case reports. Gynecol Obstet Invest 2022; 87: 259-265.","journal-title":"Gynecol Obstet Invest"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"831859","DOI":"10.3389\/fendo.2022.831859","article-title":"GnRH agonist and hCG (dual trigger) versus hCG trigger for final oocyte maturation in expected normal Responders with a high immature oocyte rate: study protocol for a randomized, superiority, parallel group, controlled trial","volume":"13","author":"Yan","year":"2022","unstructured":"Yan MH, Cao JX, Hou JW, Jiang WJ, Wang DD, Sun ZG and Song JY. GnRH agonist and hCG (dual trigger) versus hCG trigger for final oocyte maturation in expected normal Responders with a high immature oocyte rate: study protocol for a randomized, superiority, parallel group, controlled trial. Front Endocrinol (Lausanne) 2022; 13: 831859.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2507026","DOI":"10.1155\/2024\/2507026","article-title":"Comparison of HCG trigger versus dual trigger in improving pregnancy outcomes in patients with different ovarian responses: a retrospective study","volume":"2024","author":"Xu","year":"2024","unstructured":"Xu K, Wang J, Yang S, Wang Z, Hou N and Sun M. Comparison of HCG trigger versus dual trigger in improving pregnancy outcomes in patients with different ovarian responses: a retrospective study. Int J Endocrinol 2024; 2024: 2507026.","journal-title":"Int J Endocrinol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1093\/humrep\/dead024","article-title":"Regulation of human oocyte maturation in vivo during the final maturation of follicles","volume":"38","author":"Cadenas","year":"2023","unstructured":"Cadenas J, Poulsen LC, Nikiforov D, Grøndahl ML, Kumar A, Bahnu K, Englund ALM, Malm J, Marko-Varga G, Pla I, Sanchez A, Pors SE and Andersen CY. Regulation of human oocyte maturation in vivo during the final maturation of follicles. Hum Reprod 2023; 38: 686-700.","journal-title":"Hum Reprod"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"2180933","DOI":"10.1155\/2021\/2180933","article-title":"Clinical pregnancy and incidence of ovarian hyperstimulation syndrome in high ovarian responders receiving different doses of hCG supplementation in a GnRH-agonist trigger protocol","volume":"2021","author":"Shen","year":"2021","unstructured":"Shen X, Yang Q, Li L and Lu W. Clinical pregnancy and incidence of ovarian hyperstimulation syndrome in high ovarian responders receiving different doses of hCG supplementation in a GnRH-agonist trigger protocol. Evid Based Complement Alternat Med 2021; 2021: 2180933.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12958-022-00929-y","article-title":"Effect of artificial cycle with or without GnRH-a pretreatment on pregnancy and neonatal outcomes in women with PCOS after frozen embryo transfer: a propensity score matching study","volume":"20","author":"Wang","year":"2022","unstructured":"Wang Y, Hu WH, Wan Q, Li T, Qian Y, Chen MX, Tang XJ, Feng Q, Meng XQ, Adu-Gyamfi EA, Ding YB, Geng LH, Lv XY and Zhong ZH. Effect of artificial cycle with or without GnRH-a pretreatment on pregnancy and neonatal outcomes in women with PCOS after frozen embryo transfer: a propensity score matching study. Reprod Biol Endocrinol 2022; 20: 56.","journal-title":"Reprod Biol Endocrinol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2217263","DOI":"10.1080\/09513590.2023.2217263","article-title":"Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function","volume":"39","author":"Xu","year":"2023","unstructured":"Xu S, Wang X, Zhang Y, Han Y and Zhang C. Comparison the effects of progestin-primed ovarian stimulation (PPOS) protocol and GnRH-a long protocol in patients with normal ovarian reserve function. Gynecol Endocrinol 2023; 39: 2217263.","journal-title":"Gynecol Endocrinol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s42000-024-00559-6","article-title":"The effect of GnRH-a on the angiogenesis of endometriosis","volume":"23","author":"Filindris","year":"2024","unstructured":"Filindris T, Papakonstantinou E, Keramida M, Panteris E, Kalogeropoulos S, Georgopoulos N, Taniguchi F, Adonakis G, Harada T and Kaponis A. The effect of GnRH-a on the angiogenesis of endometriosis. Hormones (Athens) 2024; 23: 509-515.","journal-title":"Hormones (Athens)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"875779","DOI":"10.3389\/fendo.2022.875779","article-title":"GnRH antagonist protocol versus GnRH agonist long protocol: a retrospective cohort study on clinical outcomes and maternal-neonatal safety","volume":"13","author":"Zhu","year":"2022","unstructured":"Zhu J, Xing W, Li T, Lin H and Ou J. GnRH antagonist protocol versus GnRH agonist long protocol: a retrospective cohort study on clinical outcomes and maternal-neonatal safety. Front Endocrinol (Lausanne) 2022; 13: 875779.","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0159137.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:59:35Z","timestamp":1766023175000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/16\/11\/ajtr0159137.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/qkpv5157","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}